Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals, Inc. is a pharmaceutical company specializing in therapeutics for chronic diseases. The company's primary revenue-generating product is Probuphine, an implant for the maintenance treatment of opioid use disorder. Additionally, Titan is developing a range of products utilizing its ProNeura drug delivery platform, including a kappa opioid agonist peptide program for chronic pruritus, a nalmefene implant program for opioid relapse prevention, and other programs such as HIV preventative therapeutics and a contraceptive implant. These products form the core of Titan's business, leveraging its proprietary technology to address unmet medical needs and generate revenue.

Products

• Probuphine implant for opioid use disorder

• Kappa opioid agonist peptide program

• Nalmefene implant program

• HIV preventative therapeutics

• Contraceptive implant